Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jiangxia Du, Hao Yan, Zhifei Xu, Bo Yang, Qiaojun He, Xiaohong Wang & Peihua Luo. (2021) Cutaneous toxicity of FDA-approved small-molecule kinase inhibitors. Expert Opinion on Drug Metabolism & Toxicology 17:11, pages 1311-1325.
Read now
Read now
Hao Xu & Qi Liu. (2020) Individualized Management of Blood Concentration in Patients with Gastrointestinal Stromal Tumors. OncoTargets and Therapy 13, pages 13345-13355.
Read now
Read now
Adnan Asif Parvez Ghias, Shahzeem Bhayani, David J. Gemmel & Sudershan K. Garg. (2018) Rapidly progressive dyspnea in gastrointestinal stromal tumor (GIST) with imatinib cardiac toxicity. Journal of Community Hospital Internal Medicine Perspectives 8:2, pages 87-91.
Read now
Read now
Articles from other publishers (24)
Kritamorn Jitrangsri, Ei Mon Khaing, Torsak Intaraphairot, Thawatchai Phaechamud & Jongjan Mahadlek. (2023) Injectable Gamboge-Based In Situ Gel for Sustained Delivery of Imatinib Mesylate. Gels 9:9, pages 737.
Crossref
Crossref
Ryugo Teranishi, Tsuyoshi Takahashi, Toshirou Nishida, Yukinori Kurokawa, Kiyokazu Nakajima, Masahiro Koh, Takahiko Nishigaki, Takuro Saito, Kazuyoshi Yamamoto, Kotaro Yamashita, Koji Tanaka, Tomoki Makino, Masaaki Motoori, Takeshi Omori, Seiichi Hirota, Yoshito Hayashi, Tetsuo Takehara, Hidetoshi Eguchi & Yuichiro Doki. (2023) Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST. International Journal of Clinical Oncology 28:5, pages 680-687.
Crossref
Crossref
Neha & Suhel Parvez. (2023) Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer’s disease. Ageing Research Reviews 85, pages 101815.
Crossref
Crossref
Robert J. Ferguson, Jessica Manculich, Hsuan Chang, Nikita J. Sareen, Beth E. Snitz, Lauren Terhorst, Dana H. Bovbjerg & Anette U. Duensing. (2022) Self‐reported cognitive impairments and quality of life in patients with gastrointestinal stromal tumor: Results of a multinational survey. Cancer 128:22, pages 4017-4026.
Crossref
Crossref
Yi Hua, Xiaowen Dai, Yuan Xu, Guomeng Xing, Haichun Liu, Tao Lu, Yadong Chen & Yanmin Zhang. (2022) Drug repositioning: Progress and challenges in drug discovery for various diseases. European Journal of Medicinal Chemistry 234, pages 114239.
Crossref
Crossref
Paulina Sobierajska, Anna Serwotka-Suszczak, Damian Szymanski, Krzysztof Marycz & Rafal J. Wiglusz. (2020) Nanohydroxyapatite-Mediated Imatinib Delivery for Specific Anticancer Applications. Molecules 25:20, pages 4602.
Crossref
Crossref
E. B. Myakoshina & S. V. Saakyan. (2020) A rare case of eye complications of gastric stromal tumor treatment using imatinib mesylate. Russian Ophthalmological Journal 13:3, pages 88-91.
Crossref
Crossref
Hasan Rehman, Nausheen Hakim, Ryan Sugarman, Nagashree Seetharamu & Muhammad W Saif. (2020) Hyperpigmentation due to imatinib: A rare case of cutaneous involvement. Journal of Oncology Pharmacy Practice 26:6, pages 1511-1515.
Crossref
Crossref
Manish Kumar, Nirmal Singh & Amteshwar Singh Jaggi. (2020) Exploring the anti-stress effects of imatinib and tetrabenazine in cold-water immersion-induced acute stress in mice. Naunyn-Schmiedeberg's Archives of Pharmacology 393:9, pages 1625-1634.
Crossref
Crossref
Yanzhe Xia, Sile Chen, Meijuan Luo, Jingjing Wu, Shirong Cai, Yulong He, Xiao Chen & Xinhua Zhang. (2020) Correlations between imatinib plasma trough concentration and adverse reactions in Chinese patients with gastrointestinal stromal tumors. Cancer 126:S9, pages 2054-2061.
Crossref
Crossref
Jieying WangTaomin BaiNana WangHongyan LiXiangyang Guo. (2020) Neuroprotective potential of imatinib in global ischemia-reperfusion-induced cerebral injury: possible role of Janus-activated kinase 2/signal transducer and activator of transcription 3 and connexin 43. The Korean Journal of Physiology & Pharmacology 24:1, pages 11.
Crossref
Crossref
Sri Yadlapalli, Ammar Sukari & Misako Nagasaka. 2020. Handbook of Cancer Treatment-Related Symptons and Toxicities. Handbook of Cancer Treatment-Related Symptons and Toxicities
165
178
.
Bożena Karolewicz, Agata Górniak, Dominik M. Marciniak & Igor Mucha. (2019) Molecular Mobility and Stability Studies of Amorphous Imatinib Mesylate. Pharmaceutics 11:7, pages 304.
Crossref
Crossref
Lauren Theiss & Carlo M. Contreras. (2019) Gastrointestinal Stromal Tumors of the Stomach and Esophagus. Surgical Clinics of North America 99:3, pages 543-553.
Crossref
Crossref
Manish Kumar, Ritu Kulshrestha, Nirmal Singh & Amteshwar Singh Jaggi. (2019) Expanding spectrum of anticancer drug, imatinib, in the disorders affecting brain and spinal cord. Pharmacological Research 143, pages 86-96.
Crossref
Crossref
Jian Li, Ming Wang, Bo Zhang, Xin Wu, Tian-Long Lin, Xiu-Feng Liu, Ye Zhou, Xin-Hua Zhang, Hao Xu, Li-Jing Shen, Jing Zou, Ping Lu, Dong Zhang, Wei-Jun Gu, Mei-Xia Zhang, Jian Pan & Hui Cao. (2018) Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors. World Journal of Gastroenterology 24:46, pages 5189-5202.
Crossref
Crossref
Eytan Ben-Ami, Maria C. Castells, Nathan T. Connell, Anna E. Rutherford & Katherine A. Thornton. (2018) Imatinib-induced drug reaction with eosinophilia and systemic symptoms in solid tumors. Anti-Cancer Drugs 29:9, pages 919-923.
Crossref
Crossref
Erica K. Evans, Alexandra K. GardinoJoseph L. Kim, Brian L. Hodous, Adam ShutesAlison Davis, Xing Julia Zhu, Oleg Schmidt-Kittler, Doug WilsonKevin WilsonLucian DiPietroYulian ZhangNatasja Brooijmans, Timothy P. LaBranche, Agnieszka WozniakYemarshet K. GebreyohannesPatrick Schöffski, Michael C. Heinrich, Daniel J. DeAngeloStephen MillerBeni WolfNancy Kohl, Timothy Guzi, Nicholas Lydon, Andy Boral & Christoph Lengauer. (2017)
A precision therapy against cancers driven by
KIT/PDGFRA
mutations
. Science Translational Medicine 9:414.
Crossref
Crossref
C.I. Edvard Smith. (2017) Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC). Seminars in Cancer Biology 45, pages 36-49.
Crossref
Crossref
Elise M. O’Connell, Olena Kamenyeva, Sara Lustigman, Aaron Bell & Thomas B. Nutman. (2017) Defining the target and the effect of imatinib on the filarial c-Abl homologue. PLOS Neglected Tropical Diseases 11:7, pages e0005690.
Crossref
Crossref
Yanli Lu, Fei Mao, Xiaokang Li, Xinyu Zheng, Manjiong Wang, Qing Xu, Jin Zhu & Jian Li. (2017) Discovery of Potent, Selective Stem Cell Factor Receptor/Platelet Derived Growth Factor Receptor Alpha (c-KIT/PDGFRα) Dual Inhibitor for the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs). Journal of Medicinal Chemistry 60:12, pages 5099-5119.
Crossref
Crossref
Li Min, Cassandra Garbutt, Chongqi Tu, Francis Hornicek & Zhenfeng Duan. (2017) Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets. International Journal of Molecular Sciences 18:4, pages 731.
Crossref
Crossref
Teppei Tokumaru, Takehiro Okabayashi, Yasuo Shima, Yuichi Shibuya, Kazuhide Ozaki, Tatsuaki Sumiyoshi, Akihito Kozuki, Fuminori Teraishi, Toshio Nakamura, Manabu Matsumoto, Jun Iwata, Sojiro Morita & Tatsuo Iiyama. (2016) Surgical Management in Patients with Gastrointestinal Stromal Tumors: A Single-Center Experience. Oncology 90:5, pages 273-279.
Crossref
Crossref
Jacob Carlson, Wilson Alobuia & Jason Mizell. (2016) Rectal gastrointestinal stromal tumor with metastasis to the penis: Case report and review of literature. International Journal of Surgery Case Reports 29, pages 172-175.
Crossref
Crossref